Clinical value of plasmablasts in predicting disease relapse in patients with IgG4-related disease

被引：0
作者：
Yiwen Wang
Zheng Zhao
Dai Gao
Hui Wang
Simin Liao
Gui Luo
Xiaojian Ji
Yan Li
Xiuru Wang
Yurong Zhao
Kunpeng Li
Jie Zhang
Jingyu Jin
Yamei Zhang
Jian Zhu
Jianglin Zhang
Feng Huang
机构：
[1] Chinese PLA General Hospital,Department of Rheumatology and Immunology, First Medical Center
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Biomarker; Disease relapse; Glucocorticoids; IgG4-related disease; Immunosuppressive agents; Leflunomide; Plasmablasts;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：135 / 143
页数：8
相关论文
共 50 条
  • [1] Clinical value of plasmablasts in predicting disease relapse in patients with IgG4-related disease (Sept, 10.1007/s10067-022-06339-0, 2022)
    Wang, Yiwen
    Zhao, Zheng
    Gao, Dai
    Wang, Hui
    Liao, Simin
    Luo, Gui
    Ji, Xiaojian
    Li, Yan
    Wang, Xiuru
    Zhao, Yurong
    Li, Kunpeng
    Zhang, Jie
    Jin, Jingyu
    Zhang, Yamei
    Zhu, Jian
    Zhang, Jianglin
    Huang, Feng
    CLINICAL RHEUMATOLOGY, 2023, 42 (01) : 315 - 317
  • [2] Predictors of disease relapse in IgG4-related disease following rituximab
    Wallace, Zachary S.
    Mattoo, Hamid
    Mahajan, Vinay S.
    Kulikova, Maria
    Lu, Leo
    Deshpande, Vikram
    Choi, Hyon K.
    Pillai, Shiv
    Stone, John H.
    RHEUMATOLOGY, 2016, 55 (06) : 1000 - 1008
  • [3] Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease
    Lin, Wei
    Zhang, Panpan
    Chen, Hua
    Chen, Yu
    Yang, Hongxian
    Zheng, Wenjie
    Zhang, Xuan
    Zhang, Fengxiao
    Zhang, Wen
    Lipsky, Peter E.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [4] Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease
    Wei Lin
    Panpan Zhang
    Hua Chen
    Yu Chen
    Hongxian Yang
    Wenjie Zheng
    Xuan Zhang
    Fengxiao Zhang
    Wen Zhang
    Peter E. Lipsky
    Arthritis Research & Therapy, 19
  • [5] IgG4-related disease: a clinical perspective
    Maritati, Federica
    Peyronel, Francesco
    Vaglio, Augusto
    RHEUMATOLOGY, 2020, 59 : 123 - 131
  • [6] IgG4-related disease
    Schirmer, Jan H.
    Hoyer, Bimba F.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (24) : 1726 - 1730
  • [7] Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial
    Wang, Yiwen
    Zhao, Zheng
    Gao, Dai
    Wang, Hui
    Liao, Simin
    Dong, Chongya
    Luo, Gui
    Ji, Xiaojian
    Li, Yan
    Wang, Xiuru
    Zhao, Yurong
    Li, Kunpeng
    Zhang, Jie
    Jin, Jingyu
    Zhang, Yamei
    Zhu, Jian
    Zhang, Jianglin
    Huang, Feng
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (06) : 1513 - 1520
  • [8] De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease
    Mattoo, Hamid
    Mahajan, Vinay S.
    Della-Torre, Emanuel
    Sekigami, Yurie
    Carruthers, Mollie
    Wallace, Zachary S.
    Deshpande, Vikram
    Stone, John H.
    Pillai, Shiv
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (03) : 679 - 687
  • [9] Identification of Markers Predicting Clinical Course in Patients with IgG4-Related Ophthalmic Disease by Unbiased Clustering Analysis
    Tsubota, Kinya
    Usui, Yoshihiko
    Nemoto, Rey
    Goto, Hiroshi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 21
  • [10] Emerging therapy options for IgG4-related disease
    Lanzillotta, Marco
    Fernandez-Codina, Andreu
    Culver, Emma
    Ebbo, Mikael
    Martinez-Valle, Fernando
    Schleinitz, Nicolas
    Della-Torre, Emanuel
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (05) : 471 - 483
12345